Connection
Craig Friesen to Follow-Up Studies
This is a "connection" page, showing publications Craig Friesen has written about Follow-Up Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.178 |
|
|
|
-
Turner D, Wolters VM, Russell RK, Shakhnovich V, Muise AM, Ledder O, Ngan B, Friesen C. Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel disease. J Pediatr Gastroenterol Nutr. 2013 May; 56(5):492-7.
Score: 0.102
-
Deacy AD, Friesen CA, Staggs VS, Schurman JV. Evaluation of clinical outcomes in an interdisciplinary abdominal pain clinic: A retrospective, exploratory review. World J Gastroenterol. 2019 Jun 28; 25(24):3079-3090.
Score: 0.039
-
Shakhnovich V, Abdel-Rahman S, Friesen CA, Weigel J, Pearce RE, Gaedigk A, Leeder JS, Kearns GL. Lean body weight dosing avoids excessive systemic exposure to proton pump inhibitors for children with obesity. Pediatr Obes. 2019 01; 14(1).
Score: 0.037